Effectiveness of cell culture-based influenza vaccines compared with egg-based vaccines: What does the literature say?

被引:7
作者
Alvarez Aldean, Javier [1 ]
Salamanca, Ignacio [2 ]
Ocana, Daniel [3 ]
Luis Barranco, Jose [4 ]
Walter, Stefan [5 ]
机构
[1] Hosp Costa del Sol, Pediat Dept, Malaga, Spain
[2] Inst Hispalense Pediat, Studies & Res Unit, Seville, Spain
[3] Hlth Ctr, Algeciras Norte, Cadiz, Spain
[4] Hosp Reina Sofia, Med Prevent, Cordoba, Spain
[5] Univ Rey Juan Carlos, Dept Med Specialties & Publ Hlth, Emerging Res Epidemiol & Diag Infect Dis, Madrid, Spain
关键词
Influenza; influenza virus; egg-based vaccine; cell culture-based vaccine; DOUBLE-BLIND; PHASE-III; IMMUNOGENICITY; MULTICENTER; VIRUSES; SAFETY;
D O I
10.37201/req/117.2021
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Introduction. Influenza vaccination is an effective way of reducing the burden of seasonal influenza. Chicken egg embryos are the most common source of influenza vaccines, but cell culture production has emerged as an alternative that could be advantageous. This article reviews the available literature on the efficacy/effectiveness of cell culture-based influenza vaccines compared with egg-based vaccines. Methods. We conducted a review of the actual literature and analyzed those studies comparing the effectiveness of cell culture-based and egg-based vaccines in the last ten years. Results. Eight studies were analyzed; 1 was a clinical trial and 7 were retrospective cohort studies. The clinical trial found no significant differences in the efficacy of both vaccines with respect to placebo. The results of the observational studies were inconsistent and relative effectiveness varied among studies, even though most were performed during the same season, and in some cases, in the same region and using the same data records. Furthermore, in most studies, the comparisons between vaccines were not statistically significant. Conclusions. There is insufficient evidence that cell culture-based vaccines are superior to egg-based vaccines in terms of efficacy/effectiveness.
引用
收藏
页码:241 / 248
页数:8
相关论文
共 32 条
  • [1] Agencia Espanola de Medicamentos y Productos Sanitarios (AEMPS), 2020, FLUC TETR FICH TECN
  • [2] A novel mammalian cell-culture technique for consistent production of a well-tolerated and immunogenic trivalent subunit influenza vaccine
    Ambrozaitis, Arvydas
    Groth, Nicola
    Bugarini, Roberto
    Sparacio, Vittoria
    Podda, Audino
    Lattanzi, Maria
    [J]. VACCINE, 2009, 27 (43) : 6022 - 6029
  • [3] Cell-based influenza vaccines: Progress to date
    Audsley, Jennifer M.
    Tannock, Gregory A.
    [J]. DRUGS, 2008, 68 (11) : 1483 - 1491
  • [4] Immunogenicity and safety of a cell culture-based quadrivalent influenza vaccine in adults: A Phase III, double-blind, multicenter, randomized, non-inferiority study
    Bart, Stephan
    Cannon, Kevin
    Herrington, Darrell
    Mills, Richard
    Forleo-Neto, Eduardo
    Lindert, Kelly
    Mateen, Ahmed Abdul
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (09) : 2278 - 2288
  • [5] Relative Effectiveness of the Cell-Cultured Quadrivalent Influenza Vaccine Compared to Standard, Egg-derived Quadrivalent Influenza Vaccines in Preventing Influenza-like Illness in 2017-2018
    Boikos, Constantina
    Sylvester, Gregg C.
    Sampalis, John S.
    Mansi, James A.
    [J]. CLINICAL INFECTIOUS DISEASES, 2020, 71 (10) : E665 - E671
  • [6] The biology of influenza viruses
    Bouvier, Nicole M.
    Palese, Peter
    [J]. VACCINE, 2008, 26 : D49 - D53
  • [7] Comparison of vaccine effectiveness against influenza hospitalization of cell-based and egg-based influenza vaccines, 2017-2018
    Bruxvoort, Katia J.
    Luo, Yi
    Ackerson, Bradley
    Tanenbaum, Hilary C.
    Sy, Lina S.
    Gandhi, Ashesh
    Tseng, Hung Fu
    [J]. VACCINE, 2019, 37 (39) : 5807 - 5811
  • [8] Castilla J, 2013, EUROSURVEILLANCE, V18, P17
  • [9] Comparing influenza vaccine effectiveness between cell-derived and egg-derived vaccines, 2017-2018 influenza season
    DeMarcus, Laurie
    Shoubaki, Lisa
    Federinko, Susan
    [J]. VACCINE, 2019, 37 (30) : 4015 - 4021
  • [10] European Centre for Disease Prevention and Control (ECDC), FACTSH SEAS INFLUENZ